News & Events
Magnetically Applied MicroRNAs Could One Day Help Relieve Constipation
Micro metal beads and magnets help deliver a biologic where it’s needed to improve constipation or rectoanal incontinence in animal models of the disorders.
Reactive Oxygen Species Stop Mitochondria in Their Tracks
To satisfy the cell’s energy needs, reactive oxygen species halt mitochondria by tampering with the molecular machinery that anchors these power-generating organelles to their motor proteins.
Jefferson Centralizing Corporate Services at 1101 Market as Expansion Continues
Jefferson announced today that it will be centralizing and relocating corporate services to a new Jefferson center at 1101 Market Street, the former Aramark Headquarters.
Researchers Find New Way to Study, Combat a Deadly Tropical Disease
Findings may help scientists develop treatments to help overcome this common parasitic infection
Clarity in Vision
Researchers peer into the eye to understand how the lens forms from a collection of progenitor cells into a structure unlike any other in the body.
Phase III Immunotherapy Trial for Migraine Shows Positive Results
An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of headaches that chronic migraine patients experience per month in a phase III trial.
Could Surgery Reduce Frailty in Adults with Heart Failure?
Patients showed a reduction in measures of frailty after surgery for left-ventricular-assist-device (LVAD) surgery.
Using a Mathematical Lens to Look at Disease as a Whole Body Problem
A novel computational method allows researchers to parse how multiple organs contribute to a disease over time, giving a more holistic view of disease and potentially revealing new avenues for intervention.
Shape Matters: Cells’ Ability to Transport an Essential Protein Depends on its 3-D Conformation
Researchers reveal that the protein RCC1’s overall structure, not its distinct amino acid sequence, determines whether it’s fast-tracked into nuclei.
Jefferson and Monell Center Sign Letter of Intent to Merge
The proposed merger would combine Monell, the world's leader in taste and smell research, with research operations at the new Jefferson (Philadelphia University + Thomas Jefferson University) and Jefferson Health.